INVESTMENT

Relmada Therapeutics director buys $64,750 in company stock

Moderator - Tomas KauerModerator - Tomas Kauer
Sep 12, 2024 - 00:00
Relmada Therapeutics director buys $64,750 in company stock
Read More

Tags:

Previous Article

Cyanotech executive Michael A. Davis buys shares worth $8,350

Next Article

Humacyte CEO sells over $2.3 million in company stock

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Moderator - Tomas Kauer
Moderator - Tomas Kauer

Related Posts

A Brief Look at the Evolution of EV Battery Technology

A Brief Look at the Evolution of EV Battery Technology

Moderator - Tomas... Sep 24, 2024

North faces ‘Armageddon’ without HS2 links, warns Andy Burnham

North faces ‘Armageddon’ without HS2 links, warns Andy ...

Moderator - Tomas... Sep 25, 2024

The Role of Online Casinos in Business: A Comprehensive Analysis

The Role of Online Casinos in Business: A Comprehensive...

Moderator - Tomas... Sep 16, 2024